Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Kiang

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 27, 2017
Effects of Extended Cannabis Abstinence on Cognitive Outcomes in Cannabis Dependent Patients with Schizophrenia vs Non-Psychiatric ControlsRachel A Rabin, Mera S Barr, Michelle S Goodman, et al.
Brain, Behavior, and Immunity|June 16, 2018
TSPO expression and brain structure in the psychosis spectrumSina Hafizi, Elisa Guma, Alex Koppel, et al.
Schizophrenia Research|January 27, 2019
Relationships between cognitive event-related brain potential measures in patients at clinical high risk for psychosisJennifer R Lepock, Sarah Ahmed, Romina Mizrahi, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 13, 2025
Adaptation of a Psychosocial Intervention for Canadian Youth at Clinical High Risk for Psychosis: Adaptation d'une intervention psychosociale pour les jeunes à haut risque clinique de psychose au CanadaYun Lu, Thea L Hedemann, Lisa D Hawke, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 12, 2018
Interaction between TSPO-a neuroimmune marker-and redox status in clinical high risk for psychosis: a PET-MRS studySina Hafizi, Tania Da Silva, Jeffrey H Meyer, et al.
Biological Psychiatry|May 11, 2020
Imaging Brain Fatty Acid Amide Hydrolase in Untreated Patients With PsychosisJeremy J Watts, Maya R Jacobson, Nittha Lalang, et al.
The International Journal of Neuropsychopharmacology|April 5, 2018
Glutathione, the Major Redox Regulator, in the Prefrontal Cortex of Individuals at Clinical High Risk for PsychosisTania Da Silva, Sina Hafizi, Ana C Andreazza, et al.
Schizophrenia (Heidelberg, Germany)|February 25, 2022
Investigating repetitive transcranial magnetic stimulation on cannabis use and cognition in people with schizophreniaKarolina Kozak Bidzinski, Darby J E Lowe, Marcos Sanches, et al.
JMIR Human Factors|May 9, 2025
Assessing the Impact on Electronic Health Record Burden After Five Years of Physician Engagement in a Canadian Mental Health Organization: Mixed-Methods StudyTania Tajirian, Brian Lo, Gillian Strudwick, et al.
Clinical EEG and Neuroscience|September 25, 2020
Special Report on the Impact of the COVID-19 Pandemic on Clinical EEG and Research and Consensus Recommendations for the Safe Use of EEGSalvatore Campanella, Kemal Arikan, Claudio Babiloni, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 27, 2017
Effects of Extended Cannabis Abstinence on Cognitive Outcomes in Cannabis Dependent Patients with Schizophrenia vs Non-Psychiatric ControlsRachel A Rabin, Mera S Barr, Michelle S Goodman, et al.
Brain, Behavior, and Immunity|June 16, 2018
TSPO expression and brain structure in the psychosis spectrumSina Hafizi, Elisa Guma, Alex Koppel, et al.
Schizophrenia Research|January 27, 2019
Relationships between cognitive event-related brain potential measures in patients at clinical high risk for psychosisJennifer R Lepock, Sarah Ahmed, Romina Mizrahi, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 13, 2025
Adaptation of a Psychosocial Intervention for Canadian Youth at Clinical High Risk for Psychosis: Adaptation d'une intervention psychosociale pour les jeunes à haut risque clinique de psychose au CanadaYun Lu, Thea L Hedemann, Lisa D Hawke, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 12, 2018
Interaction between TSPO-a neuroimmune marker-and redox status in clinical high risk for psychosis: a PET-MRS studySina Hafizi, Tania Da Silva, Jeffrey H Meyer, et al.
Biological Psychiatry|May 11, 2020
Imaging Brain Fatty Acid Amide Hydrolase in Untreated Patients With PsychosisJeremy J Watts, Maya R Jacobson, Nittha Lalang, et al.
The International Journal of Neuropsychopharmacology|April 5, 2018
Glutathione, the Major Redox Regulator, in the Prefrontal Cortex of Individuals at Clinical High Risk for PsychosisTania Da Silva, Sina Hafizi, Ana C Andreazza, et al.
Schizophrenia (Heidelberg, Germany)|February 25, 2022
Investigating repetitive transcranial magnetic stimulation on cannabis use and cognition in people with schizophreniaKarolina Kozak Bidzinski, Darby J E Lowe, Marcos Sanches, et al.
JMIR Human Factors|May 9, 2025
Assessing the Impact on Electronic Health Record Burden After Five Years of Physician Engagement in a Canadian Mental Health Organization: Mixed-Methods StudyTania Tajirian, Brian Lo, Gillian Strudwick, et al.
Clinical EEG and Neuroscience|September 25, 2020
Special Report on the Impact of the COVID-19 Pandemic on Clinical EEG and Research and Consensus Recommendations for the Safe Use of EEGSalvatore Campanella, Kemal Arikan, Claudio Babiloni, et al.
Pageof 7